SuperworthBioAge Labs market cap BIOA
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $234.1M
- Highest close in our data
- $1.1B
- Jul 2026
BioAge Labs is worth $234.1M at the close on Oct 23, 2026, at $5.10 a share.
That is down 14% over the last year.
Its highest close in our data was $1.1B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $234.1M | $222.1M | $1.1B | −53% |
| 2025 | $497.7M | $117.9M | $497.7M | +152% |
| 2024 | $197.2M | $153.4M | $795.5M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest BioAge Labs' size, closest first, today.
| Company | Market cap |
|---|---|
| BIOABioAge Labs | $234.1M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| LFVNLifevantage | $73.4M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $570.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on BioAge Labs
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.